Logo image of HA

HAWAIIAN HOLDINGS INC (HA) Stock Fundamental Analysis

NASDAQ:HA - Nasdaq - US4198791018 - Common Stock - Currency: USD

18  +0.68 (+3.93%)

After market: 17.99 -0.01 (-0.06%)

Fundamental Rating

1

Overall HA gets a fundamental rating of 1 out of 10. We evaluated HA against 23 industry peers in the Passenger Airlines industry. Both the profitability and financial health of HA have multiple concerns. HA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year HA has reported negative net income.
HA had a negative operating cash flow in the past year.
HA had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: HA reported negative operating cash flow in multiple years.
HA Yearly Net Income VS EBIT VS OCF VS FCFHA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M -400M

1.2 Ratios

HA has a worse Return On Assets (-8.37%) than 60.00% of its industry peers.
Industry RankSector Rank
ROA -8.37%
ROE N/A
ROIC N/A
ROA(3y)-5.3%
ROA(5y)-4.66%
ROE(3y)-123.49%
ROE(5y)-86.98%
ROIC(3y)N/A
ROIC(5y)N/A
HA Yearly ROA, ROE, ROICHA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200

1.3 Margins

Looking at the Gross Margin, with a value of 3.44%, HA is doing worse than 84.00% of the companies in the same industry.
HA's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for HA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 3.44%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-27.13%
HA Yearly Profit, Operating, Gross MarginsHA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40 -60

2

2. Health

2.1 Basic Checks

HA does not have a ROIC to compare to the WACC, probably because it is not profitable.
HA has more shares outstanding than it did 1 year ago.
HA has more shares outstanding than it did 5 years ago.
HA has a worse debt/assets ratio than last year.
HA Yearly Shares OutstandingHA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M
HA Yearly Total Debt VS Total AssetsHA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B

2.2 Solvency

HA has an Altman-Z score of 0.45. This is a bad value and indicates that HA is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.45, HA is doing worse than 64.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.45
ROIC/WACCN/A
WACC7.12%
HA Yearly LT Debt VS Equity VS FCFHA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M 1B 1.5B

2.3 Liquidity

HA has a Current Ratio of 1.11. This is a normal value and indicates that HA is financially healthy and should not expect problems in meeting its short term obligations.
HA has a better Current ratio (1.11) than 92.00% of its industry peers.
HA has a Quick Ratio of 1.06. This is a normal value and indicates that HA is financially healthy and should not expect problems in meeting its short term obligations.
HA's Quick ratio of 1.06 is amongst the best of the industry. HA outperforms 92.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 1.06
HA Yearly Current Assets VS Current LiabilitesHA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

3

3. Growth

3.1 Past

HA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -130.79%.
HA shows a decrease in Revenue. In the last year, the revenue decreased by -0.63%.
HA shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.87% yearly.
EPS 1Y (TTM)-130.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-191.49%
Revenue 1Y (TTM)-0.63%
Revenue growth 3Y47.6%
Revenue growth 5Y-0.87%
Sales Q2Q%3.53%

3.2 Future

HA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.32% yearly.
HA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.21% yearly.
EPS Next Y-34.63%
EPS Next 2Y16.35%
EPS Next 3Y23.32%
EPS Next 5YN/A
Revenue Next Year5.33%
Revenue Next 2Y8.9%
Revenue Next 3Y9.21%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
HA Yearly Revenue VS EstimatesHA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B
HA Yearly EPS VS EstimatesHA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 5 -5 -10

1

4. Valuation

4.1 Price/Earnings Ratio

HA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year HA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HA Price Earnings VS Forward Price EarningsHA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HA Per share dataHA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

A more expensive valuation may be justified as HA's earnings are expected to grow with 23.32% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.35%
EPS Next 3Y23.32%

0

5. Dividend

5.1 Amount

HA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

HAWAIIAN HOLDINGS INC

NASDAQ:HA (9/17/2024, 8:11:05 PM)

After market: 17.99 -0.01 (-0.06%)

18

+0.68 (+3.93%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)07-30 2024-07-30/amc
Earnings (Next)10-22 2024-10-22/amc
Inst Owners1.44%
Inst Owner Change-1.44%
Ins Owners2.76%
Ins Owner Change0%
Market Cap936.18M
Analysts76.92
Price Target13.01 (-27.72%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.44%
Min EPS beat(2)1.03%
Max EPS beat(2)1.85%
EPS beat(4)3
Avg EPS beat(4)-1.28%
Min EPS beat(4)-9.87%
Max EPS beat(4)1.88%
EPS beat(8)7
Avg EPS beat(8)10.31%
EPS beat(12)11
Avg EPS beat(12)10.94%
EPS beat(16)12
Avg EPS beat(16)9.57%
Revenue beat(2)0
Avg Revenue beat(2)-2.55%
Min Revenue beat(2)-4.71%
Max Revenue beat(2)-0.38%
Revenue beat(4)0
Avg Revenue beat(4)-2.99%
Min Revenue beat(4)-4.71%
Max Revenue beat(4)-0.38%
Revenue beat(8)0
Avg Revenue beat(8)-2.79%
Revenue beat(12)2
Avg Revenue beat(12)-2.46%
Revenue beat(16)3
Avg Revenue beat(16)-3.69%
PT rev (1m)10.87%
PT rev (3m)13.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-228.63%
EPS NY rev (1m)0%
EPS NY rev (3m)-36.75%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.13%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.26%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.34
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-7.57
EYN/A
EPS(NY)-3.92
Fwd EYN/A
FCF(TTM)-13
FCFYN/A
OCF(TTM)-5.74
OCFYN/A
SpS53.34
BVpS-2.03
TBVpS-2.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.37%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 3.44%
FCFM N/A
ROA(3y)-5.3%
ROA(5y)-4.66%
ROE(3y)-123.49%
ROE(5y)-86.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-27.13%
F-Score1
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 282.72%
Cap/Sales 13.62%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.11
Quick Ratio 1.06
Altman-Z 0.45
F-Score1
WACC7.12%
ROIC/WACCN/A
Cap/Depr(3y)93.49%
Cap/Depr(5y)119.87%
Cap/Sales(3y)4.98%
Cap/Sales(5y)8.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-130.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-191.49%
EPS Next Y-34.63%
EPS Next 2Y16.35%
EPS Next 3Y23.32%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.63%
Revenue growth 3Y47.6%
Revenue growth 5Y-0.87%
Sales Q2Q%3.53%
Revenue Next Year5.33%
Revenue Next 2Y8.9%
Revenue Next 3Y9.21%
Revenue Next 5YN/A
EBIT growth 1Y-138.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year83.85%
EBIT Next 3Y40.56%
EBIT Next 5YN/A
FCF growth 1Y-292.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-122.31%
OCF growth 3YN/A
OCF growth 5YN/A